Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Isotretinoin effectively improved severe pityriasis rubra pilaris with complications.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Serenoa repens extract may help hair growth in both men and women.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Older men with late-onset lupus have a higher mortality rate than women.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Robertsonian translocation can cause recurrent miscarriages.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

SIM01 significantly reduced post-COVID symptoms and is safe.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.